[go: up one dir, main page]

MX2008011396A - Ligandos alfa-2-delta para sueño no reconstituyente. - Google Patents

Ligandos alfa-2-delta para sueño no reconstituyente.

Info

Publication number
MX2008011396A
MX2008011396A MX2008011396A MX2008011396A MX2008011396A MX 2008011396 A MX2008011396 A MX 2008011396A MX 2008011396 A MX2008011396 A MX 2008011396A MX 2008011396 A MX2008011396 A MX 2008011396A MX 2008011396 A MX2008011396 A MX 2008011396A
Authority
MX
Mexico
Prior art keywords
alpha
restorative sleep
delta ligands
delta
restorative
Prior art date
Application number
MX2008011396A
Other languages
English (en)
Inventor
Timothy James Griffin
Bruce Gerald Mccarthy
David Young Mitchell
Daniele Marie-Claude Ouellet
Theresa Papa Stern
John Werth Jr
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MX2008011396A publication Critical patent/MX2008011396A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe el uso de un ligando alfa-2-delta o una sal farmacéuticamente aceptable del mismo para el tratamiento del sueño no reconstituyente.
MX2008011396A 2006-03-06 2007-02-22 Ligandos alfa-2-delta para sueño no reconstituyente. MX2008011396A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77963606P 2006-03-06 2006-03-06
PCT/IB2007/000458 WO2007102058A1 (en) 2006-03-06 2007-02-22 Alpha-2-delta ligands for non-restorative sleep

Publications (1)

Publication Number Publication Date
MX2008011396A true MX2008011396A (es) 2008-09-18

Family

ID=37945967

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008011396A MX2008011396A (es) 2006-03-06 2007-02-22 Ligandos alfa-2-delta para sueño no reconstituyente.

Country Status (15)

Country Link
US (2) US20090069427A1 (es)
EP (1) EP1993529A1 (es)
JP (1) JP2007238613A (es)
KR (1) KR20080100284A (es)
CN (1) CN101420947A (es)
AR (1) AR059761A1 (es)
AU (1) AU2007222112A1 (es)
BR (1) BRPI0708671A2 (es)
CA (1) CA2640402C (es)
IL (1) IL193809A0 (es)
MX (1) MX2008011396A (es)
RU (1) RU2008135907A (es)
TW (1) TW200800157A (es)
WO (1) WO2007102058A1 (es)
ZA (1) ZA200807445B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100491282B1 (ko) 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
CN1303059C (zh) * 1997-10-27 2007-03-07 沃尼尔·朗伯公司 作为药物的环状氨基酸及其衍生物
US7164034B2 (en) * 1999-06-10 2007-01-16 Pfizer Inc. Alpha2delta ligands for fibromyalgia and other disorders
EP1296671B1 (en) * 2000-06-26 2008-03-26 Warner-Lambert Company LLC Gabapentin analogues for sleep disorders
NI200300043A (es) * 2002-03-28 2003-11-05 Warner Lambert Co AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA.
US20040092522A1 (en) * 2002-08-15 2004-05-13 Field Mark John Synergistic combinations
KR100845932B1 (ko) * 2002-12-13 2008-07-11 워너-램버트 캄파니 엘엘씨 섬유근육통 및 기타 관련 질환의 치료를 위한 프레가발린및 그의 유도체
AU2003283718A1 (en) * 2002-12-13 2004-07-09 Warner-Lambert Company Llc Gabapentin analogues for fibromyalgia and other related disorders
KR20060087560A (ko) * 2003-09-12 2006-08-02 워너-램버트 캄파니 엘엘씨 알파-2-델타 리간드 및 ｓｓｒｉ 및/또는 ｓｎｒｉ를포함하는 우울증 및 불안 장애 치료용 조합물
MXPA06003395A (es) * 2003-09-25 2006-06-08 Warner Lambert Co Aminoacidos con afinidad por la proteina a2d.
US20050222209A1 (en) * 2004-04-01 2005-10-06 Zeldis Jerome B Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease

Also Published As

Publication number Publication date
TW200800157A (en) 2008-01-01
EP1993529A1 (en) 2008-11-26
US20120065265A1 (en) 2012-03-15
AU2007222112A1 (en) 2007-09-13
IL193809A0 (en) 2009-08-03
KR20080100284A (ko) 2008-11-14
AR059761A1 (es) 2008-04-30
CA2640402A1 (en) 2007-09-13
WO2007102058A1 (en) 2007-09-13
RU2008135907A (ru) 2010-04-20
CN101420947A (zh) 2009-04-29
BRPI0708671A2 (pt) 2011-06-07
US20090069427A1 (en) 2009-03-12
JP2007238613A (ja) 2007-09-20
CA2640402C (en) 2012-01-03
ZA200807445B (en) 2009-11-25

Similar Documents

Publication Publication Date Title
MY146111A (en) Acylaminopyrazoles as fgfr inhibitors
TW200738725A (en) Unsaturated mTOR inhibitors
TW200740776A (en) N-phenylbenzotriazolyl c-kit inhibitors
IL228904A0 (en) Use of milankiperan, or a suitable pharmaceutical salt, in the preparation of a drug for the treatment of fibromyalgia
TW200801006A (en) Fused bicyclic mTOR inhibitors
MX2010004435A (es) Compuestos espiro y uso farmaceutico de los mismos.
UA98141C2 (ru) Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа
UA115320C2 (uk) Інгібітори кінази
SG150531A1 (en) Use of meloxicam for the treatment of respiratory diseases in pigs
NZ593440A (en) Aminopyrazole compounds useful for inhibiting chk1
IL191542A0 (en) Use of phenyl-hydrazine- indole derivatives for the manufacture fo medicaments for modulating thrombopoietin activity
EP4424375A3 (en) Antineoplastic combinations of neratinib and capecitabine
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
UA96969C2 (en) Acylaminopyrazoles as fgfr inhibitors
IL178116A0 (en) Prevention of retinopathy by inhibition of the visual cycle
IL240394B (en) Use of alemtuzumab to prepare a drug for use as a secondary treatment in multiple sclerosis
EP1757282A4 (en) USE OF KAURANE COMPOUNDS IN THE MANUFACTURE OF MEDICAMENTS
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
MX2008010804A (es) Derivados de rapamicina para tratar neuroblastoma.
MX2008011396A (es) Ligandos alfa-2-delta para sueño no reconstituyente.
IL177609A (en) Use of gobacoline or its analogue to produce a drug to treat liver carcinoma
TW200631584A (en) A medicament related to mirtazapine for the treatment of hot flush
GB0313386D0 (en) Treatment of disease
MX2008011312A (es) Analogos de meridamicina para el tratamiento de trastornos neurodegenerativos.
DE602006008339D1 (en) Zolpidemtabletten